Global single-cell omics market size is estimated to be valued at US$ 1.63 Bn in 2023 and is expected to reach US$ 4.62 Bn by 2030, exhibited a compound annual growth (CAGR) of 16% from 2023 to 2030. Single-cell omics is the profiling of single cells that are sampled from heterogeneous population of cells from different cellular states, where the normal development and disease processes can be studied and dissected at a single-cell resolution
Global Single-cell Omics Market Regional Insights
- North America is accounted for the largest market share of over 55% in 2023, and is projected to remain dominant over the forecast period. The high prevalence of cancer, the presence of key market players are the key factors driving the growth of the market in this region.
- Europe is the second-largest market for single-cell omics. Increasing product launches. Market players are focusing on organic strategies is expected to aid in the market growth over the forecast period.
- Asia Pacific is the fastest-growing market for single-cell omics due to research and developmental (R&D) activities by the market players is expected to drive the market growth over the forecast period
Figure 1. Global Single-cell Omics Market Share (%), By Region, 2023
To learn more about this report, request a free sample copy
Analyst View Global Single-cell Omics Market:
Global single-cell omics market is expected to grow at a rapid rate due to advancements in single-cell sequencing technologies and increased resolution of cellular heterogeneity. A growing focus on personalized medicine and the demand for targeted therapies in oncology and other diseases is expected to aid in the market growth over the forecast period.
Global Single-cell Omics Market Drivers
- Growing Application Areas: Global single-cell omics market is experiencing significant growth due to expanding application areas of Omics technologies. Single omics refers to the study of various biological molecules including genomics, proteomics or metabolomics in isolation. Traditionally, these Omics areas were studied separately to gain insights into life sciences challenges. However, with advancement in high-throughput technologies, researchers are able to apply single Omics approaches to real-world problems more comprehensively.
- Increasing R&D Funding: Increasing funding and grant from the market players and governments is expected to aid in the market growth. For instance, on September 12, 2023, Fluent BioSciences, a cutting edge life sciences company, announced the award of an NIH Small Business Innovation Research (SBIR) Phase II grant, funded by the National Institute of General Medical Sciences (NIGMS, 1 R44 GM1376648). This funding will advance the commercialization of groundbreaking methods and reagents for high-throughput single cell analysis.
Global Single-cell Omics Market Report Coverage
| Report Coverage |
Details |
|---|
| Base Year: |
2022 |
Market Size in 2023: |
US$ 1.63 Bn |
|---|
| Historical Data for: |
2018 to 2021 |
Forecast Period: |
2023 – 2030 |
|---|
| Forecast Period 2023 to 2030 CAGR: |
16% |
2030 Value Projection: |
US$ 4.62 Bn |
|---|
| Geographies covered: |
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East: GCC Countries, Israel, Rest of Middle East
- Africa: South Africa, Central Africa, North Africa
|
| Segments covered: |
- By Technology: Single-cell RNA Sequencing, Single-cell DNA Sequencing, Single-cell Proteomics, Single-cell Multi-omics, Single-cell Imaging, and Others
- By Product: Instruments and Consumables
- By Application: Cancer research, Immunology, Neuroscience, Stem cell research, Developmental biology, and Others
- By End User: Pharmaceutical & Biotechnology Company, CRO, and Others (Research Institutes, etc.)
|
| Companies covered: |
Bio-Rad Laboratories Inc., Agilent Technologies Inc., QIAGEN N.V., Thermo Fisher Scientific, Illumina Inc., Roche, Bio-Techne, and Pacific Biosciences
|
| Growth Drivers: |
- Growing application areas
- Increasing R&D funding
|
| Restraints & Challenges: |
|
Global Single-cell Omics Market Opportunities
- Collaboration and Partnerships: Market players are focusing on inorganics strategies such as merger and collaboration which is expected to drive the market growth over the forecast period. For instance, on June 17, 2022, Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible and NanoCellect Biomedical, Inc., which provides solution for solutions for cell sorting, announced a collaboration to improve resolution and efficacy of single cell ribonucleic acid (RNA) sequencing analysis of rare cell populations.
Global Single-cell Omics Market Trends
- Automation: The rise of automation and artificial intelligence (AI) technologies is significantly impacting the global single-cell omics market. Automation is allowing for higher throughput and precision in omics workflows such as genomics, proteomics and metabolomics. Robotic liquid handling systems and automated analyzers can perform repetitive tasks like nucleic acid extractions, library preparations and running assays faster and more accurately than humans. This enables laboratories to process larger sample volumes around the clock to generate omics data.
Global Single-cell Omics Market Restraints
- Technical challenges: The growth of the global single-cell omics market is facing considerable technical challenges which are restraining its trajectory. One of the major hurdles is the limitation of single-cell omics approach itself where it examines only one type of biomolecule such as deoxyribonucleic acid (DNA), ribonucleic acid (RNA) or proteins in isolation. This provides an incomplete picture of complex biological systems as various omics data such as genome, transcriptome, proteome and metabolome influence each other. Studying them separately through traditional single omics methods make it difficult to understand how biological pathways interact as a whole network. This is a significant drawback in the post-genomic era where understanding the system-wide level interplay between different biomolecules is critical.
Counterbalance: The technical challenge of studying of various omics data should be analyzed properly, in counterbalancing the biomolecules.
Recent Developments
New product launches
- On October 29, 2020, Mission Bio, Inc., a biotechnology company, launched a complete tapestri single-cell multi-omics solution.
- On September 11, 2023, MGI, a company committed to building core tools and technology to lead life science, announced the DCS Lab Initiative to help facilitate large-scale leading multi-omics laboratories and spur critical scientific research.
Figure 2. Global Single-cell Omics Market Share (%), By Product Type, 2023
To learn more about this report, request a free sample copy
Top Companies in Global Single-cell Omics Market
- Bio-Rad Laboratories Inc.
- Agilent Technologies Inc.
- QIAGEN N.V.
- Thermo Fisher Scientific
- Illumina Inc.
- Roche
- Bio-Techne
- Pacific Biosciences
Definition: Single-cell omics is the profiling of single cells that are sampled from heterogeneous population of cells from different cellular states, where the normal development and disease processes can be studied and dissected at a single-cell resolution.
Few other promising reports in Biotechnology Industry
Spatial Omics Market
U.S.: 
U.K. : 
India :